BIRAC Announces Request for Expression Of Interest REOI under MISSION COVID SURAKSHA – Development of COVID-19 vaccine candidates
To ensure accelerated development of a vaccine for COVID-19, the objective of this REOI is to support Regulatory toxicology studies, manufacturing clinical trial material, and clinical development for licensure of COVID-19 vaccine candidates, and other activities to ensure accelerated development of vaccine candidates such that within the next 12 months they are closer to licensure and introduction in the market.
The proposals can be submitted by any one of the following:
- Company (Start-up, Small, Medium, or Large), LLP incorporated under the Companies Act, 2013, having a minimum of 51% of the shares of the Company to be held by Indian Citizens (Indian passport holders).
- Academia (Public or Private Research Institute, University) having a well-established support system for research. The institute should have been established in India and have NAAC/ UGC/ AICTE or any equivalent recognition certificate or any other Public/Government supported organization
- Non-profit organizations/ Society/ Trusts/ Foundation/ Associations/ Government entities/ Institutes/ R&D Organizations/ which is a legal entity
Announcement Date: 01-12-2020
Last Submission Date: 15-01-2021 05:00 PM
More on: https://birac.nic.in/cfp_view.